Business Week found a couple of people to debate whether health insurance companies should have to reimburse patients for genetic tests. Philip Reilly from Interleukin Genetics says they should, arguing that patients have a right to know whether they're at risk for various diseases. "Living to your fullest means pursuing a healthful life style, which you can do, and managing your genetic risks, which you can do only if you have been tested," he writes.